| |
| |
|
| Insider
Information: |
Kennedy Giulia C |
| Relationship: |
Chief Scientific & Med... |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
65,970 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,327,316 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
65,970 |
|
|
| Total
Value |
$1,327,316 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Veracyte, Inc. |
VCYT |
Chief Scientific & Med... |
2022-12-06 |
65,970 |
2019-02-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-12-06 |
4 |
AS |
$27.03 |
$27,652 |
D/D |
(1,023) |
65,970 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-12-02 |
4 |
D |
$29.14 |
$29,373 |
D/D |
(1,008) |
66,993 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-11-11 |
4 |
AS |
$29.34 |
$59 |
D/D |
(2) |
68,001 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-11-11 |
4 |
OE |
$14.34 |
$29 |
D/D |
2 |
68,003 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-11-04 |
4 |
AS |
$25.00 |
$25,575 |
D/D |
(1,023) |
68,001 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-09-02 |
4 |
D |
$19.18 |
$19,333 |
D/D |
(1,008) |
69,024 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-08-05 |
4 |
AS |
$26.54 |
$27,283 |
D/D |
(1,028) |
70,032 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-08-05 |
4 |
OE |
$5.43 |
$39 |
D/D |
5 |
71,060 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-08-05 |
4 |
A |
$0.00 |
$0 |
D/D |
10,702 |
71,055 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-06-02 |
4 |
D |
$18.23 |
$18,376 |
D/D |
(1,008) |
60,353 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-03-04 |
4 |
OE |
$5.98 |
$26,354 |
D/D |
4,407 |
84,394 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-03-04 |
4 |
AS |
$24.91 |
$577,783 |
D/D |
(23,003) |
61,391 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-03-04 |
4/A |
AS |
$24.91 |
$578,535 |
D/D |
(23,033) |
61,361 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
42,412 |
79,987 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2022-03-02 |
4 |
D |
$27.84 |
$287,782 |
D/D |
(10,337) |
37,575 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2021-12-07 |
4 |
AS |
$39.69 |
$246,356 |
D/D |
(6,125) |
47,912 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2021-12-07 |
4 |
OE |
$24.69 |
$154,481 |
D/D |
6,125 |
54,037 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2021-12-06 |
4 |
AS |
$35.37 |
$332,784 |
D/D |
(9,232) |
47,912 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2021-12-06 |
4 |
OE |
$5.98 |
$102,135 |
D/D |
8,156 |
57,144 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2021-12-02 |
4 |
D |
$39.22 |
$35,769 |
D/D |
(912) |
48,988 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2021-11-01 |
4 |
D |
$51.80 |
$7,718 |
D/D |
(149) |
49,900 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2021-09-08 |
4 |
AS |
$50.53 |
$46,791 |
D/D |
(926) |
50,049 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2021-09-07 |
4 |
AS |
$50.52 |
$633,408 |
D/D |
(12,531) |
50,975 |
0 |
% |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2021-09-07 |
4 |
OE |
$5.98 |
$210,154 |
D/D |
12,531 |
63,506 |
0 |
- |
|
| VCYT |
Veracyte, Inc. |
Chief Scientific & Med Officer |
• – – |
2021-09-02 |
4 |
D |
$52.97 |
$48,309 |
D/D |
(912) |
50,975 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
